Mobile Menu
Greece
GR GR-C210 | Industry Report | Factsheet

Pharmaceuticals, Medicinal Chemical & Botanical Product Manufacturing in Greece Industry Data and Analysis

II
IBISWorld
Analyst London, United Kingdom August 2024

The Pharmaceuticals, Medicinal Chemical & Botanical Product Manufacturing industry in Greece has a market size of €2.5bn in 2026 with annual revenue growth of 4.4 %. This division includes the manufacture of basic pharmaceutical products and pharmaceutical preparations. This includes also the manufacture of medicinal chemical and botanical products.

Access this data your way

The Pharmaceuticals, Medicinal Chemical & Botanical Product Manufacturing in Greece Industry analysis is available in multiple formats to fit seamlessly into your workflow.

IBISWorld Industry Report platform

IBISWorld Platform

Answer any industry question in minutes with our entire database at your fingertips.

Screen of code example for the IBISWorld api

API Data Delivery

Feed trusted, human-driven industry intelligence straight into your platform.

IBISWorld Data integration with a Client user interface

Integrations

Streamline your workflow with IBISWorld’s intelligence built into your toolkit.

What's included in this industry analysis

IBISWorld's research coverage on the Pharmaceuticals, Medicinal Chemical & Botanical Product Manufacturing industry in Greece includes market sizing, forecasting, data and analysis. The most recent publication will be as current as of February 2026.

About this industry

What's this industry report about?

The Pharmaceuticals, Medicinal Chemical & Botanical Product Manufacturing industry in Greece operates under the industry code GR-C210. This division includes the manufacture of basic pharmaceutical products and pharmaceutical preparations. This includes also the manufacture of medicinal chemical and botanical products. Related terms covered in the Pharmaceuticals, Medicinal Chemical & Botanical Product Manufacturing industry in Greece include api (active pharmaceutical ingredient), biosimilars and orphan drug.

What's included in this industry?

Products and services covered in Pharmaceuticals, Medicinal Chemical & Botanical Product Manufacturing industry in Greece include .

What companies are included in this industry?

The Pharmaceuticals, Medicinal Chemical & Botanical Product Manufacturing industry in Greece is highly fragmented with no companies holding a market share greater than 5%.

Performance

What's included in the Performance chapter?

The Performance chapter covers detailed analysis, datasets, detailed current performance, sources of volatility and an outlook with forecasts for the Pharmaceuticals, Medicinal Chemical & Botanical Product Manufacturing industry in Greece.

Competitive Forces

What's included in the Competitive Forces chapter?

The Competitive Forces chapter covers the concentration, barriers to entry and supplier and buyer profiles in the Pharmaceuticals, Medicinal Chemical & Botanical Product Manufacturing industry in Greece. This includes data and statistics on industry market share concentration, barriers to entry, substitute products and buyer & supplier power.

External Environment

What's included in the External Environment chapter?

The External Environment chapter covers Key Takeaways, External Drivers, Regulation & Policy and Assistance in the Pharmaceuticals, Medicinal Chemical & Botanical Product Manufacturing industry in Greece. This includes data and statistics on factors impacting industry revenue such as economic indicators, regulation, policy and assistance programs.

Financial Benchmarks

What's included in the Financial Benchmarks chapter?

The Financial Benchmarks chapter covers Key Takeaways, Cost Structure, Financial Ratios, Valuation Multiples and Key Ratios in the Pharmaceuticals, Medicinal Chemical & Botanical Product Manufacturing industry in Greece. This includes financial data and statistics on industry performance including key cost inputs, profitability, key financial ratios and enterprise value multiples.

Country Benchmarks

What's included in the Country Benchmarks chapter?

The Financial Benchmarks chapter covers Key Takeaways, Cost Structure, Financial Ratios, Valuation Multiples and Key Ratios in the Cafes and Coffee Shops industry in Australia. This includes financial data and statistics on industry performance including key cost inputs, profitability, key financial ratios and enterprise value multiples.

Questions answered in this chapter include what trends impact industry costs and how financial ratios have changed overtime.

Industry Data

What's included in the Industry Data chapter?

The Industry Data chapter includes 10 years of historical data with 5 years of forecast data covering statistics like revenue, industry value add, establishments, enterprises, employment and wages in the Pharmaceuticals, Medicinal Chemical & Botanical Product Manufacturing industry in Greece.

Trusted by industry professionals

More than 6,000 businesses use IBISWorld to shape local and global economies

We were able to supplement our reports with IBISWorld’s information from both a qualitative and quantitative standpoint. All of our reporting now features some level of IBISWorld integration.

BDO logo

IBISWorld delivers the crisp business knowledge we need to drive our business.  Whether it be serving up our major clients, winning new business or educating  on industry issues, IBISWorld brings real value.

PWC logo

IBISWorld has revolutionised business information — which has proved commercially invaluable to exporters, investors and public policy professionals in Australia and overseas.

Australian Trade and Investment Commission logo

When you’re able to speak to clients and be knowledgeable about what they do and the state that they operate in, they’re going to trust you a lot more.

Citi Bank logo

10,000,000+ Data points

100% Industry analyst verified

50,000 + Industry titles

Frequently Asked Questions

What is the market size of the Pharmaceuticals, Medicinal Chemical & Botanical Product Manufacturing industry in Greece in 2026?

The market size of the Pharmaceuticals, Medicinal Chemical & Botanical Product Manufacturing industry in Greece is €2.5bn in 2026.

How many businesses are there in the Pharmaceuticals, Medicinal Chemical & Botanical Product Manufacturing industry in Greece in 2024?

There are 131 businesses in the Pharmaceuticals, Medicinal Chemical & Botanical Product Manufacturing industry in Greece, which has declined at a CAGR of 0.0 % between 2019 and 2024.

Has the Pharmaceuticals, Medicinal Chemical & Botanical Product Manufacturing industry in Greece grown or declined over the past 5 years?

The market size of the Pharmaceuticals, Medicinal Chemical & Botanical Product Manufacturing industry in Greece has been declining at a CAGR of 0.1 % between 2019 and 2024.

What is the forecast growth of the Pharmaceuticals, Medicinal Chemical & Botanical Product Manufacturing industry in Greece over the next 5 years?

Over the next five years, the Pharmaceuticals, Medicinal Chemical & Botanical Product Manufacturing industry in Greece is expected to grow.

What does the Pharmaceuticals, Medicinal Chemical & Botanical Product Manufacturing industry in Greece include?

Medicinal active substances and Processing of blood are part of the Pharmaceuticals, Medicinal Chemical & Botanical Product Manufacturing industry in Greece.

How competitive is the Pharmaceuticals, Medicinal Chemical & Botanical Product Manufacturing industry in Greece?

The level of competition is moderate and increasing in the Pharmaceuticals, Medicinal Chemical & Botanical Product Manufacturing industry in Greece.

Cut through the noise with intelligence you can trust

/img/content/home/cta-image-1.webp
/img/content/home/cta-image-2.webp
/img/content/home/cta-image-3.webp
/img/content/home/cta-image-4.webp
/img/content/home/cta-image-5.webp